Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer (Q27851456)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer |
scientific article |
Statements
10 December 2008
0 references
26
0 references
5705-12
0 references
35
0 references